Replies to post #160017 on Biotech Values

[hptaxis]

Top-Line Data Show Exact Sciences' Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal Cancer
All endpoints achieved in 10,000-patient trial of non-invasive, convenient DNA-based screening test for colorectal cancer and pre-cancerous polyps
http://investor.exactsciences.com/releasedetail.cfm?ReleaseID=757341